Esflurbiprofen Topical System (EFTS)
Sponsors
Teikoku Seiyaku Co. Ltd., Teikoku Seiyaku Co., Ltd.
Conditions
Acute ankle sprains grade IAnkle SprainsContusionsacute contusion of the upper or lower limbs
Phase 3
An open label, multi-centric trial to assess the safety and efficacy of an Esflurbiprofen Topical System (EFTS) in the local symptomatic and short-term treatment of pain in contusions.
CompletedCTIS2024-513064-26-00
Start: 2025-02-12End: 2025-10-01Target: 219Updated: 2025-09-15
Randomized, controlled, double-blind, multi-center trial to evaluate the efficacy and safety of an Esflurbiprofen Topical System (EFTS) vs. placebo in the local symptomatic and short-term treatment of pain in ankle sprains.
CompletedCTIS2024-513063-45-00
Start: 2025-03-06End: 2025-10-30Target: 110Updated: 2025-09-12
Phase III Trial to Evaluate the Efficacy and Safety in Patients With Ankle Sprains.
CompletedNCT06866613
Start: 2025-03-31End: 2025-10-30Updated: 2025-11-26
Phase III Trial to Assess the Safety and Efficacy of TK-254RX in Patients With Contusions
CompletedNCT06871046
Start: 2025-02-20End: 2025-10-01Updated: 2025-10-24